Published in J Gastrointest Surg on June 27, 2002
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Extended esophagectomy in elderly patients with esophageal cancer: minor effect of age alone in determining the postoperative course and survival. Ann Surg Oncol (2010) 2.13
Presentation and prognosis of esophageal adenocarcinoma in patients below age 50. Dig Dis Sci (2008) 0.82
Barrett's esophagus: now what? Ann Surg (2003) 0.75
Clinicopathological features and prognosis of patients <45 years old with esophageal adenocarcinoma comparing to other age groups. J Thorac Dis (2016) 0.75
Minimally invasive esophagectomy in the elderly. Indian J Surg Oncol (2013) 0.75
A model for three-point analysis of random general transduction. Genetics (1966) 16.23
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (1996) 11.13
An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med (1970) 9.83
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg (1997) 8.86
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg (2001) 8.34
The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg (1995) 5.95
One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg (1993) 5.87
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg (1995) 5.66
Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg (1987) 5.58
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet (1994) 4.63
Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res (1997) 4.54
A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg (1995) 4.24
Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg (1998) 4.19
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res (2001) 4.19
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg (1997) 3.90
Clinical prediction rule for pulmonary infiltrates. Ann Intern Med (1990) 3.81
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res (2000) 3.74
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res (1996) 3.60
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol (1993) 3.56
Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol (1990) 3.53
Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res (1995) 3.33
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol (2001) 3.27
Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg (1993) 3.17
Pyogenic hepatic abscess. Changing trends over 42 years. Ann Surg (1996) 3.13
Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg (1999) 3.09
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02
Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg (2000) 2.94
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
Selective nonoperative management of contained intrathoracic esophageal disruptions. Ann Thorac Surg (1979) 2.90
Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res (1998) 2.89
p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res (1994) 2.80
Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg (2001) 2.80
LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate (2000) 2.79
Intensive care unit physician staffing is associated with decreased length of stay, hospital cost, and complications after esophageal resection. Crit Care Med (2001) 2.69
Ferrous-activated nicotinamide adenine dinucleotide-linked dehydrogenase from a mutant of Escherichia coli capable of growth on 1, 2-propanediol. J Bacteriol (1969) 2.66
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation. Am J Pathol (2000) 2.63
Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg (1998) 2.60
Chronic pancreatic ascites and pancreatic pleural effusions. Gastroenterology (1978) 2.60
Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol (1999) 2.59
Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol (1992) 2.54
Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg (1997) 2.53
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res (2001) 2.50
Postoperative bile duct strictures: management and outcome in the 1990s. Ann Surg (2000) 2.50
Acute pancreatitis with hyperlipemia: the incidence of lipid abnormalities in acute pancreatitis. Ann Surg (1973) 2.47
Laparoscopic cholecystectomy-related bile duct injuries: a health and financial disaster. Ann Surg (1997) 2.41
Factors affecting mortality in biliary tract surgery. Am J Surg (1981) 2.41
Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res (2000) 2.40
Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg (1999) 2.37
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg (1999) 2.36
Choledochal cyst disease. A changing pattern of presentation. Ann Surg (1994) 2.33
Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg (1998) 2.32
Surgical management of unresectable carcinoma of the pancreas. Surgery (1982) 2.30
Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol (2001) 2.30
Split pectoralis major muscle flap reconstruction after clavicular-manubrial resection. Ann Thorac Surg (1999) 2.29
Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus. J Virol (2001) 2.28
Mutants of Aerobacter aerogenes capable of utilizing xylitol as a novel carbon. J Bacteriol (1968) 2.28
Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg (1995) 2.28
Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res (1994) 2.26
Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg (1993) 2.26
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res (1998) 2.23
Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg (1999) 2.23
Carcinoid tumor of the gallbladder: laparoscopic resection and review of the literature. Surgery (1992) 2.18
Cecal volvulus: analysis of 50 patients with long-term follow-up. Ann Surg (1979) 2.13
Allelotype of pancreatic adenocarcinoma. Cancer Res (1994) 2.11
Laparoscopic cholecystectomy. Surg Clin North Am (1990) 2.11
Purification and properties of lactaldehyde dehydrogenase from Escherichia coli. J Biol Chem (1969) 2.11
Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J Sci Am (1998) 2.03
Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol (1988) 2.03
Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg (2000) 2.00
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98
Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res (1998) 1.97
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol (2005) 1.93
The role of oxygen-derived free radicals in the pathogenesis of acute pancreatitis. Ann Surg (1984) 1.92
Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) (1982) 1.92
Variable region genes for the immunoglobulin framework are assembled from small segments of DNA--a hypothesis. Proc Natl Acad Sci U S A (1978) 1.92
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (2001) 1.89
Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg (2000) 1.86
Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains. Ann N Y Acad Sci (1971) 1.84
Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg (1998) 1.83